CBD has been shown to suppress angiogenesis and diminish the metastatic properties of breast cancer cells via the Src/VHL/HIF-1alpha signaling pathway (Sarcoma, Hypoxia-inducible factor 1-alpha, Von Hippel-Lindau Tumor Suppressor) (122). Here, VHL is linked to breast carcinoma.